E71.39
Other disorders of fatty-acid metabolism
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code E71.39 refers to other disorders of fatty-acid metabolism. These conditions involve disruptions in how the body processes fats, which are vital sources of energy and essential components of cell structures. Fatty-acid metabolism disorders can vary in severity and type, affecting different metabolic pathways and leading to a range of health issues. Recognizing these disorders is crucial for proper management and treatment, as they can impact overall health and development.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting enzymes involved in fatty acid breakdown or synthesis Inherited metabolic disorders passed down through families Deficiencies of specific enzymes necessary for fatty-acid metabolism Secondary causes related to other metabolic or nutritional deficiencies Environmental factors that influence metabolism, such as certain medications or toxins
Key Symptoms: Muscle weakness or fatigue Hypotonia (reduced muscle tone) Difficulty with exercise or physical activity Hypoglycemia (low blood sugar levels) Liver enlargement or hepatomegaly Recurrent episodes of muscle pain or cramps Erratic blood lipid levels Developmental delays in some cases, particularly in children In severe cases, episodes of metabolic crisis with vomiting, lethargy, or coma
Diagnostic & Treatment
Diagnosis Path: Diagnosis of disorders related to fatty-acid metabolism typically involves a combination of blood and urine tests to detect abnormal fatty acid levels, enzyme activity assessments, and genetic testing. Newborn screening programs may also identify some of these conditions early in life. A detailed medical history and physical examination help shape the diagnostic process, often complemented by imaging studies if organ involvement is suspected.
Treatment Protocols: Managing disorders of fatty-acid metabolism may include dietary modifications to limit the intake of specific fats or nutrients that exacerbate the condition. Supplementation with carnitine or other agents may be recommended to support proper fat metabolism. In some cases, hospitalization is necessary during metabolic crises, and specialized medical care is provided. Long-term management focuses on preventing episodes of metabolic decompensation and addressing associated symptoms, with periodic monitoring to adjust treatment plans as needed.
Clinical Advice & FAQs
Billing Guidance
Is E71.39 a billable ICD-10 code?
Yes, E71.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.39?
Clinical documentation must specify the nature of Other disorders of fatty-acid metabolism and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
